產(chǎn)品名稱 Recombinant Human Matriptase/ST14 Catalytic Domain, CF from R&D SYSTEMS, INC.
    產(chǎn)品貨號(hào) 3946-SEB-010
    產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
    產(chǎn)品規(guī)格 10 ug
    產(chǎn)品品牌 R&D SYSTEMS, INC.
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameRecombinant Human Matriptase/ST14 Catalytic Domain, CF
    DescriptionPurity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie? Blue Staining. MW (observed): 27 kDa (major) and minor auto-activation fragments, reducing conditions. MW (theoretical): 26 kDa. The Recombinant Human Matriptase/ST14 Catalytic Domain from R&D Systems is derived from E. coli. The Recombinant Human Matriptase/ST14 Catalytic Domain has been validated for the following applications: Enzyme Activity.
    Size10 ug
    Concentrationn/a
    ApplicationsEnzyme Activity
    Other NamesEC 3.4.21, Epithin, HAI, Matriptase, Membrane-type serine protease 1, MTSP1, MT-SP1EC 3.4.21.109, prostamin, PRSS14, Serine protease 14, Serine protease TADG-15, SNC19, SNC19MTSP1, ST14, suppression of tumorigenicity 14 (colon carcinoma), suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin), suppressor of tumorigenicity 14 protein, TADG15, TADG-15, TMPRSS14, tumor associated differentially expressed gene 15 protein, Tumor-associated differentially-expressed gene 15 protein
    Gene, Accession, CAS #Gene ID: 6768, Accession: NP_068813
    Catalog #3946-SEB-010
    Price
    Order / More InfoRecombinant Human Matriptase/ST14 Catalytic Domain, CF from R&D SYSTEMS, INC.
    Product Specific ReferencesPubMed: 18310226, 20601429, 20657595, 22383955, 23548907, 24617769, 27459298, 28358853, 30409910, 30606244
    產(chǎn)品資料 
    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>

    3. 

    <th id="itm00"></th>